Innovent Biologics Placement (1801.HK) - There Is No Such Thing as a Free Lunch

802 Views12 Sep 2023 12:58
Innovent's Placing this time makes people feel "uncomfortable", because the Company is actually cash rich. Although Innovent is close to breakeven, its stock price is already high, with limited upside
Boomeranged on Tue, 17 Oct 2023 09:18
Innovent's recent strong share price performance reflects the market's enthusiasm for weight loss drugs. Compared with weight loss pipeline of other domestic companies, IBI362 has more opportunities to become a Me-Better variety. Impending breakeven in financial performance would also be a catalyst. Innovent would have a position in GLP-1s field. Stock price correction is a good buying opportunity
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
(Paid Plans Only)